| SC 13G | 2017-01-30 | BlackRock Inc. | ENZO BIOCHEM INC | 2,996,621 | 6.5% | EDGAR |
| SC 13G/A | 2017-01-23 | Evermore Global Advisors, LLC | ENZO BIOCHEM INC | 3,312,792 | 1.0% | EDGAR |
| SC 13G/A | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | ENZO BIOCHEM INC | 4,215,912 | 9.2% | EDGAR |
| SC 13G/A | 2016-02-11 | DAVIDOWITZ ROSALIND | ENZO BIOCHEM INC | 2,274,977 | 4.9% | EDGAR |
| SC 13G | 2016-02-11 | WELLINGTON TRUST Co N A | ENZO BIOCHEM INC | 2,792,263 | 6.1% | EDGAR |
| SC 13G | 2016-02-08 | Evermore Global Advisors, LLC | ENZO BIOCHEM INC | 3,151,784 | 1.0% | EDGAR |
| SC 13G/A | 2015-07-10 | BlackRock Inc. | ENZO BIOCHEM INC | 1,397,706 | 3.0% | EDGAR |
| SC 13G/A | 2015-03-25 | DAVIDOWITZ ROSALIND | ENZO BIOCHEM INC | 3,041,634 | 6.8% | EDGAR |
| SC 13G/A | 2015-02-17 | RA CAPITAL MANAGEMENT, LLC | ENZO BIOCHEM INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2015-02-12 | DAVIDOWITZ ROSALIND | ENZO BIOCHEM INC | 3,565,960 | 8.0% | EDGAR |
| SC 13G | 2015-02-12 | WELLINGTON MANAGEMENT GROUP LLP | ENZO BIOCHEM INC | 2,682,082 | 6.0% | EDGAR |
| SC 13G | 2015-02-02 | BlackRock Inc. | ENZO BIOCHEM INC | 2,581,103 | 5.8% | EDGAR |
| SC 13G/A | 2014-02-14 | RA CAPITAL MANAGEMENT, LLC | ENZO BIOCHEM INC | 2,268,653 | 5.5% | EDGAR |
| SC 13G/A | 2014-02-10 | DIMENSIONAL FUND ADVISORS LP | ENZO BIOCHEM INC | 1,969,685 | 4.8% | EDGAR |
| SC 13G/A | 2014-02-06 | DAVIDOWITZ ROSALIND | ENZO BIOCHEM INC | 3,729,088 | 9.0% | EDGAR |
| SC 13G | 2013-08-09 | RA CAPITAL MANAGEMENT, LLC | ENZO BIOCHEM INC | 3,348,029 | 8.4% | EDGAR |
| SC 13G/A | 2013-02-14 | Clearbridge Investments, LLC | ENZO BIOCHEM INC | 1,590,427 | 4.0% | EDGAR |
| SC 13G | 2013-02-11 | DIMENSIONAL FUND ADVISORS LP | ENZO BIOCHEM INC | 1,967,793 | 5.0% | EDGAR |
| SC 13G/A | 2013-02-04 | DAVIDOWITZ ROSALIND | ENZO BIOCHEM INC | 3,677,718 | 9.4% | EDGAR |
| SC 13G/A | 2012-07-11 | BlackRock Inc. | ENZO BIOCHEM INC | 1,635,794 | 4.2% | EDGAR |